A federal court entered a consent decree of permanent injunction requiring a multi-site outsourcing compounding pharmacy, headquartered in Illinois, to comply with provisions of the Federal Food, Drug, and Cosmetic Act (the Act) while manufacturing, holding, and distributing drugs.